Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7001 USD | -7.76% | +11.34% | +79.51% |
18/04 | Renalytix chief business officer to become president | AN |
18/04 | Renalytix Names Chief Business Officer as President | MT |
Sales 2024 * | 4M 334M | Sales 2025 * | 18M 1.5B | Capitalization | 53.28M 4.45B |
---|---|---|---|---|---|
Net income 2024 * | -35M -2.92B | Net income 2025 * | -26M -2.17B | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.96 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.42% |
Latest transcript on Renalytix Plc
1 day | -7.76% | ||
1 week | +11.34% | ||
Current month | +1.04% | ||
1 month | -12.49% | ||
3 months | +146.43% | ||
6 months | -32.68% | ||
Current year | +79.51% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15/18/15 |
James Sterling
DFI | Director of Finance/CFO | 54 | 15/18/15 |
Howard Doran
PSD | President | 63 | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30/21/30 |
Chairman | 72 | 15/18/15 | |
James McCullough
FOU | Founder | 56 | 15/18/15 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.7001 | -7.76% | 217,898 |
02/24/02 | 0.759 | -3.92% | 532,732 |
01/24/01 | 0.79 | +14.01% | 251,363 |
30/24/30 | 0.6929 | +2.50% | 564,507 |
29/24/29 | 0.676 | +7.51% | 484,911 |
Delayed Quote Nasdaq, May 04, 2024 at 02:00 am IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.68% | 18.88B | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 637M |
- Stock Market
- Equities
- RENX Stock
- RNLX Stock